DCP
LLY icon

DSM Capital Partners’s Eli Lilly LLY Stock Holding History

DSM Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,738
Closed -$6.03M – 46
2025
Q2 		$6.03M Sell
7,738
-165
-2% -$128K 0.09% 30
2025
Q1 		$6.53M Sell
7,903
-639
-7% -$532K 0.11% 30
2024
Q4 		$6.59M Sell
8,542
-57
-0.7% -$47.2K 0.1% 29
2024
Q3 		$7.62M Buy
8,599
+878
+11% +$789K 0.12% 29
2024
Q2 		$6.99M Buy
7,721
+7,620
+7,545% +$6.1M 0.1% 27
2024
Q1 		$78.6K Buy
101
+20
+25% +$14.2K ﹤0.01% 60
2023
Q4 		$47.2K Buy
+81
New +$47.3K ﹤0.01% 65

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DSM Capital Partners's LLY Position: Q3 2025 in Review

DSM Capital Partners sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 7,738 shares — an estimated $6.03M sold.

DSM Capital Partners first reported a position in LLY in Q4 2023 and held it in 7 quarters. The position peaked at $7.62M in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • DSM Capital Partners reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • DSM Capital Partners sold 7,738 Eli Lilly shares in Q3 2025, an estimated $6.03M.
  • DSM Capital Partners first reported a position in Eli Lilly in Q4 2023 and held it in 7 quarters.
  • DSM Capital Partners's Eli Lilly position peaked at $7.62M in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on DSM Capital Partners's 13F filing for Q3 2025, filed 22 Oct 2025.